Stock Market News2 months PPBT Stock Surges 150% on Superior Efficacy of PDAC Combo Therapy Zacks
Purple Biotech stock surges 150.4% on reporting superior efficacy data from the mid-stage study of its combo therapy on pancreatic cancer patients.
XPurple Biotech stock surges 150.4% on reporting superior efficacy data from the mid-stage study of its combo therapy on pancreatic cancer patients.
X